home / stock / san / san news


SAN News and Press, Banco Santander S.A. Sponsored ADR From 03/30/22

Stock Information

Company Name: Banco Santander S.A. Sponsored ADR
Stock Symbol: SAN
Market: NYSE
Website: santander.com

Menu

SAN SAN Quote SAN Short SAN News SAN Articles SAN Message Board
Get SAN Alerts

News, Short Squeeze, Breakout and More Instantly...

SAN - Spain's Banco Santander hikes minimum wage to $20

Mardrid-based Banco Santander (NYSE:SAN) said Monday it will nudge up its minimum hourly wage to $20, nearly triple the federal minimum wage. The wage hike is available to Santander Bank, N.A. and SC U.S. employees who work onsite in branches, call centers and corporate offices. ...

SAN - Santander US Increases Minimum Wage to $20

Nearly triple the federal minimum wage Invests in team members’ financial security and career development Santander Holdings USA, Inc. ("Santander US” and “Santander”) announced today that it will increase its minimum hourly wage to $20, n...

SAN - SAN, STLA and EPAM among pre market gainers

Guardforce AI (GFAI) +46% is expanding it footprint by establishing subsidiaries in Dubai and Australia. IGM Biosciences (IGMS) +32% on proposed stock offering. Hycroft Mining Holding (HYMC) +23% GameStop, AMC and Bed Bath pull off a meme stock comeback. Nielsen Holdi...

SAN - Dupixent® (dupilumab injection) now approved in Canada for the treatment of severe asthma in children aged six to 11 years with type 2 inflammation

Dupixent® (dupilumab injection) now approved in Canada for the treatment of severe asthma in children aged six to 11 years with type 2 inflammation Canada NewsWire This is the sixth indication for Dupixent in Canada , its second in asthma, and its second in ch...

SAN - Late-breaking Phase 3 Data at AAD 2022 Show Dupixent® (dupilumab) Significantly Improved Signs and Symptoms of Prurigo Nodularis

Late-breaking Phase 3 Data at AAD 2022 Show Dupixent® (dupilumab) Significantly Improved Signs and Symptoms of Prurigo Nodularis PR Newswire TARRYTOWN, N.Y. and PARIS , March 26, 2022 /PRNewswire/ -- Dupixent significantly reduced ...

SAN - Libtayo® (cemiplimab) now approved in Canada for the treatment of recurrent or metastatic cervical cancer

Libtayo® (cemiplimab) now approved in Canada for the treatment of recurrent or metastatic cervical cancer Canada NewsWire Fourth Canadian approval of Libtayo in difficult-to-treat cancers MISSISSAUGA, ON , March 25, 2022 /CNW Telbec/ - Today ...

SAN - W. R. Berkley leads weeks' financial gainers; China fintechs drop the most

Property and casualty insurer W. R. Berkley (NYSE:WRB) +57% finished the week as the largest percentage gainer within the financial sector (with a market cap of $2B+). Cryptocurrency lender Silvergate Capital (NYSE:SI) +16.6% jumped as bitcoin (BTC-USD) gained slightly by ...

SAN - Financial stocks get some relief as Treasury yields rise, oil price surge pauses

Financial stocks bounced up in afternoon trading on Tuesday after Treasury yields rose and crude oil, though still high, eased off its peak of $130/barrel level touched on Monday. Higher Treasury yields bode well for bank earnings as they make much of their profit on net interest income. 10-y...

SAN - Late-breaking Data at 2022 AAAAI Annual Meeting Show Dupixent® (dupilumab) Significantly Improved Signs and Symptoms of Eosinophilic Esophagitis

Late-breaking Data at 2022 AAAAI Annual Meeting Show Dupixent® (dupilumab) Significantly Improved Signs and Symptoms of Eosinophilic Esophagitis PR Newswire TARRYTOWN, N.Y. and PARIS , Feb. 26, 2022 /PRNewswire/ -- Dupixent 300 mg weekly is the onl...

SAN - Santander: The Highest Banking Upside In All Of Europe

In today's article, I'm taking a bit of a step to the left (in Europe and Brazil) and moving into Spain. I'm looking at Santander. Banco Santander is a global banking institution with presence in all major financial centers on the planet. It's the 16th-largest on earth. It's a systemi...

Previous 10 Next 10